Novo Nordisk A/S (NONOF)
51.00
+2.72
(+5.63%)
USD |
OTCM |
Dec 11, 11:15
Novo Nordisk Shareholders Equity (Quarterly): 26.74B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 23.79B |
| Genmab A/S | 5.751B |
| Ascendis Pharma A/S | -204.54M |
| Evaxion AS | 10.34M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 80.64B |
| Total Liabilities (Quarterly) | 53.90B |
| Debt to Equity Ratio | 0.5957 |
| Current Ratio | 0.7761 |
| Net Debt Paydown Yield | -0.63% |